Search results for the GEO ID: GSE16179  |
(Click on the check boxes provided under "Select for analysis", to initiate grouping) |
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down) |
|
GSM ID | GPL ID |
Select for analysis |
Title |
Source name |
Description |
Characteristics |
GSM799168 | GPL570 |
|
BT474_DMSO_24-1
|
BT474 breast cancer cell line, DMSO
|
cell line: BT474
cell type: breast cancer
lapatinib sensitivity: lapatinib-sensitive
her2 status: HER2-positive
treatment: DMSO
|
Gene expression data of a breast cancer cell line.
|
| Sample_geo_accession | GSM799168
| | Sample_status | Public on Sep 20 2011
| | Sample_submission_date | Sep 20 2011
| | Sample_last_update_date | Sep 20 2011
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Homo sapiens
| | Sample_taxid_ch1 | 9606
| | Sample_treatment_protocol_ch1 | Cells were treated with vehicle (DMSO), 1 µM lapatinib, 0.1 µM GSK1363089 (foretinib) or a combination of 1µM lapatinib and 0.1 µM foretinib for 24h.
| | Sample_growth_protocol_ch1 | Cells were plated in RPMI medium containing 10% FBS overnight at 37ºC, 5%CO2.
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Trizol extraction of total RNA was performed according to the manufacturer's instructions.
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | Biotinylated cRNA were prepared according to the standard Affymetrix protocol (Response Genetics, Inc.)
| | Sample_hyb_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_scan_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_data_processing | RNA microarray signals were normalized by MAS5. QC and data analysis were performed using Omicsoft microarray analysis tools (http://www.omicsoft.com/).
| | Sample_platform_id | GPL570
| | Sample_contact_name | Yuan,,Liu
| | Sample_contact_fax | 610-917-5000
| | Sample_contact_department | Biomarker
| | Sample_contact_institute | GlaxoSmithKline
| | Sample_contact_address | 1250 South Collegeville Rd
| | Sample_contact_city | Collegeville
| | Sample_contact_state | PA
| | Sample_contact_zip/postal_code | 19446
| | Sample_contact_country | USA
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM799nnn/GSM799168/suppl/GSM799168.CEL.gz
| | Sample_series_id | GSE16179
| | Sample_data_row_count | 54675
| | |
|
GSM799169 | GPL570 |
|
BT474_DMSO_24-2
|
BT474 breast cancer cell line, DMSO
|
cell line: BT474
cell type: breast cancer
lapatinib sensitivity: lapatinib-sensitive
her2 status: HER2-positive
treatment: DMSO
|
Gene expression data of a breast cancer cell line.
|
| Sample_geo_accession | GSM799169
| | Sample_status | Public on Sep 20 2011
| | Sample_submission_date | Sep 20 2011
| | Sample_last_update_date | Sep 20 2011
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Homo sapiens
| | Sample_taxid_ch1 | 9606
| | Sample_treatment_protocol_ch1 | Cells were treated with vehicle (DMSO), 1 µM lapatinib, 0.1 µM GSK1363089 (foretinib) or a combination of 1µM lapatinib and 0.1 µM foretinib for 24h.
| | Sample_growth_protocol_ch1 | Cells were plated in RPMI medium containing 10% FBS overnight at 37ºC, 5%CO2.
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Trizol extraction of total RNA was performed according to the manufacturer's instructions.
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | Biotinylated cRNA were prepared according to the standard Affymetrix protocol (Response Genetics, Inc.)
| | Sample_hyb_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_scan_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_data_processing | RNA microarray signals were normalized by MAS5. QC and data analysis were performed using Omicsoft microarray analysis tools (http://www.omicsoft.com/).
| | Sample_platform_id | GPL570
| | Sample_contact_name | Yuan,,Liu
| | Sample_contact_fax | 610-917-5000
| | Sample_contact_department | Biomarker
| | Sample_contact_institute | GlaxoSmithKline
| | Sample_contact_address | 1250 South Collegeville Rd
| | Sample_contact_city | Collegeville
| | Sample_contact_state | PA
| | Sample_contact_zip/postal_code | 19446
| | Sample_contact_country | USA
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM799nnn/GSM799169/suppl/GSM799169.CEL.gz
| | Sample_series_id | GSE16179
| | Sample_data_row_count | 54675
| | |
|
GSM799170 | GPL570 |
|
BT474_DMSO_24-3
|
BT474 breast cancer cell line, DMSO
|
cell line: BT474
cell type: breast cancer
lapatinib sensitivity: lapatinib-sensitive
her2 status: HER2-positive
treatment: DMSO
|
Gene expression data of a breast cancer cell line.
|
| Sample_geo_accession | GSM799170
| | Sample_status | Public on Sep 20 2011
| | Sample_submission_date | Sep 20 2011
| | Sample_last_update_date | Sep 20 2011
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Homo sapiens
| | Sample_taxid_ch1 | 9606
| | Sample_treatment_protocol_ch1 | Cells were treated with vehicle (DMSO), 1 µM lapatinib, 0.1 µM GSK1363089 (foretinib) or a combination of 1µM lapatinib and 0.1 µM foretinib for 24h.
| | Sample_growth_protocol_ch1 | Cells were plated in RPMI medium containing 10% FBS overnight at 37ºC, 5%CO2.
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Trizol extraction of total RNA was performed according to the manufacturer's instructions.
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | Biotinylated cRNA were prepared according to the standard Affymetrix protocol (Response Genetics, Inc.)
| | Sample_hyb_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_scan_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_data_processing | RNA microarray signals were normalized by MAS5. QC and data analysis were performed using Omicsoft microarray analysis tools (http://www.omicsoft.com/).
| | Sample_platform_id | GPL570
| | Sample_contact_name | Yuan,,Liu
| | Sample_contact_fax | 610-917-5000
| | Sample_contact_department | Biomarker
| | Sample_contact_institute | GlaxoSmithKline
| | Sample_contact_address | 1250 South Collegeville Rd
| | Sample_contact_city | Collegeville
| | Sample_contact_state | PA
| | Sample_contact_zip/postal_code | 19446
| | Sample_contact_country | USA
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM799nnn/GSM799170/suppl/GSM799170.CEL.gz
| | Sample_series_id | GSE16179
| | Sample_data_row_count | 54675
| | |
|
GSM799171 | GPL570 |
|
BT474_Lap_24-1
|
BT474 breast cancer cell line, lapatinib
|
cell line: BT474
cell type: breast cancer
lapatinib sensitivity: lapatinib-sensitive
her2 status: HER2-positive
treatment: lapatinib
|
Gene expression data of a breast cancer cell line.
|
| Sample_geo_accession | GSM799171
| | Sample_status | Public on Sep 20 2011
| | Sample_submission_date | Sep 20 2011
| | Sample_last_update_date | Sep 20 2011
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Homo sapiens
| | Sample_taxid_ch1 | 9606
| | Sample_treatment_protocol_ch1 | Cells were treated with vehicle (DMSO), 1 µM lapatinib, 0.1 µM GSK1363089 (foretinib) or a combination of 1µM lapatinib and 0.1 µM foretinib for 24h.
| | Sample_growth_protocol_ch1 | Cells were plated in RPMI medium containing 10% FBS overnight at 37ºC, 5%CO2.
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Trizol extraction of total RNA was performed according to the manufacturer's instructions.
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | Biotinylated cRNA were prepared according to the standard Affymetrix protocol (Response Genetics, Inc.)
| | Sample_hyb_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_scan_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_data_processing | RNA microarray signals were normalized by MAS5. QC and data analysis were performed using Omicsoft microarray analysis tools (http://www.omicsoft.com/).
| | Sample_platform_id | GPL570
| | Sample_contact_name | Yuan,,Liu
| | Sample_contact_fax | 610-917-5000
| | Sample_contact_department | Biomarker
| | Sample_contact_institute | GlaxoSmithKline
| | Sample_contact_address | 1250 South Collegeville Rd
| | Sample_contact_city | Collegeville
| | Sample_contact_state | PA
| | Sample_contact_zip/postal_code | 19446
| | Sample_contact_country | USA
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM799nnn/GSM799171/suppl/GSM799171.CEL.gz
| | Sample_series_id | GSE16179
| | Sample_data_row_count | 54675
| | |
|
GSM799172 | GPL570 |
|
BT474_Lap_24-2
|
BT474 breast cancer cell line, lapatinib
|
cell line: BT474
cell type: breast cancer
lapatinib sensitivity: lapatinib-sensitive
her2 status: HER2-positive
treatment: lapatinib
|
Gene expression data of a breast cancer cell line.
|
| Sample_geo_accession | GSM799172
| | Sample_status | Public on Sep 20 2011
| | Sample_submission_date | Sep 20 2011
| | Sample_last_update_date | Sep 20 2011
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Homo sapiens
| | Sample_taxid_ch1 | 9606
| | Sample_treatment_protocol_ch1 | Cells were treated with vehicle (DMSO), 1 µM lapatinib, 0.1 µM GSK1363089 (foretinib) or a combination of 1µM lapatinib and 0.1 µM foretinib for 24h.
| | Sample_growth_protocol_ch1 | Cells were plated in RPMI medium containing 10% FBS overnight at 37ºC, 5%CO2.
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Trizol extraction of total RNA was performed according to the manufacturer's instructions.
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | Biotinylated cRNA were prepared according to the standard Affymetrix protocol (Response Genetics, Inc.)
| | Sample_hyb_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_scan_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_data_processing | RNA microarray signals were normalized by MAS5. QC and data analysis were performed using Omicsoft microarray analysis tools (http://www.omicsoft.com/).
| | Sample_platform_id | GPL570
| | Sample_contact_name | Yuan,,Liu
| | Sample_contact_fax | 610-917-5000
| | Sample_contact_department | Biomarker
| | Sample_contact_institute | GlaxoSmithKline
| | Sample_contact_address | 1250 South Collegeville Rd
| | Sample_contact_city | Collegeville
| | Sample_contact_state | PA
| | Sample_contact_zip/postal_code | 19446
| | Sample_contact_country | USA
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM799nnn/GSM799172/suppl/GSM799172.CEL.gz
| | Sample_series_id | GSE16179
| | Sample_data_row_count | 54675
| | |
|
GSM799173 | GPL570 |
|
BT474_Lap_24-3
|
BT474 breast cancer cell line, lapatinib
|
cell line: BT474
cell type: breast cancer
lapatinib sensitivity: lapatinib-sensitive
her2 status: HER2-positive
treatment: lapatinib
|
Gene expression data of a breast cancer cell line.
|
| Sample_geo_accession | GSM799173
| | Sample_status | Public on Sep 20 2011
| | Sample_submission_date | Sep 20 2011
| | Sample_last_update_date | Sep 20 2011
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Homo sapiens
| | Sample_taxid_ch1 | 9606
| | Sample_treatment_protocol_ch1 | Cells were treated with vehicle (DMSO), 1 µM lapatinib, 0.1 µM GSK1363089 (foretinib) or a combination of 1µM lapatinib and 0.1 µM foretinib for 24h.
| | Sample_growth_protocol_ch1 | Cells were plated in RPMI medium containing 10% FBS overnight at 37ºC, 5%CO2.
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Trizol extraction of total RNA was performed according to the manufacturer's instructions.
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | Biotinylated cRNA were prepared according to the standard Affymetrix protocol (Response Genetics, Inc.)
| | Sample_hyb_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_scan_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_data_processing | RNA microarray signals were normalized by MAS5. QC and data analysis were performed using Omicsoft microarray analysis tools (http://www.omicsoft.com/).
| | Sample_platform_id | GPL570
| | Sample_contact_name | Yuan,,Liu
| | Sample_contact_fax | 610-917-5000
| | Sample_contact_department | Biomarker
| | Sample_contact_institute | GlaxoSmithKline
| | Sample_contact_address | 1250 South Collegeville Rd
| | Sample_contact_city | Collegeville
| | Sample_contact_state | PA
| | Sample_contact_zip/postal_code | 19446
| | Sample_contact_country | USA
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM799nnn/GSM799173/suppl/GSM799173.CEL.gz
| | Sample_series_id | GSE16179
| | Sample_data_row_count | 54675
| | |
|
GSM799174 | GPL570 |
|
BT474-J4_DMSO_24-1
|
BT474-J4 breast cancer cell line, DMSO
|
cell line: BT474-J4
cell type: breast cancer
lapatinib sensitivity: acquired lapatinib-resistant
her2 status: HER2-positive
treatment: DMSO
|
Gene expression data of a breast cancer cell line.
|
| Sample_geo_accession | GSM799174
| | Sample_status | Public on Sep 20 2011
| | Sample_submission_date | Sep 20 2011
| | Sample_last_update_date | Sep 20 2011
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Homo sapiens
| | Sample_taxid_ch1 | 9606
| | Sample_treatment_protocol_ch1 | Cells were treated with vehicle (DMSO), 1 µM lapatinib, 0.1 µM GSK1363089 (foretinib) or a combination of 1µM lapatinib and 0.1 µM foretinib for 24h.
| | Sample_growth_protocol_ch1 | Cells were plated in RPMI medium containing 10% FBS overnight at 37ºC, 5%CO2.
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Trizol extraction of total RNA was performed according to the manufacturer's instructions.
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | Biotinylated cRNA were prepared according to the standard Affymetrix protocol (Response Genetics, Inc.)
| | Sample_hyb_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_scan_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_data_processing | RNA microarray signals were normalized by MAS5. QC and data analysis were performed using Omicsoft microarray analysis tools (http://www.omicsoft.com/).
| | Sample_platform_id | GPL570
| | Sample_contact_name | Yuan,,Liu
| | Sample_contact_fax | 610-917-5000
| | Sample_contact_department | Biomarker
| | Sample_contact_institute | GlaxoSmithKline
| | Sample_contact_address | 1250 South Collegeville Rd
| | Sample_contact_city | Collegeville
| | Sample_contact_state | PA
| | Sample_contact_zip/postal_code | 19446
| | Sample_contact_country | USA
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM799nnn/GSM799174/suppl/GSM799174.CEL.gz
| | Sample_series_id | GSE16179
| | Sample_data_row_count | 54675
| | |
|
GSM799175 | GPL570 |
|
BT474-J4_DMSO_24-2
|
BT474-J4 breast cancer cell line, DMSO
|
cell line: BT474-J4
cell type: breast cancer
lapatinib sensitivity: acquired lapatinib-resistant
her2 status: HER2-positive
treatment: DMSO
|
Gene expression data of a breast cancer cell line.
|
| Sample_geo_accession | GSM799175
| | Sample_status | Public on Sep 20 2011
| | Sample_submission_date | Sep 20 2011
| | Sample_last_update_date | Sep 20 2011
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Homo sapiens
| | Sample_taxid_ch1 | 9606
| | Sample_treatment_protocol_ch1 | Cells were treated with vehicle (DMSO), 1 µM lapatinib, 0.1 µM GSK1363089 (foretinib) or a combination of 1µM lapatinib and 0.1 µM foretinib for 24h.
| | Sample_growth_protocol_ch1 | Cells were plated in RPMI medium containing 10% FBS overnight at 37ºC, 5%CO2.
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Trizol extraction of total RNA was performed according to the manufacturer's instructions.
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | Biotinylated cRNA were prepared according to the standard Affymetrix protocol (Response Genetics, Inc.)
| | Sample_hyb_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_scan_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_data_processing | RNA microarray signals were normalized by MAS5. QC and data analysis were performed using Omicsoft microarray analysis tools (http://www.omicsoft.com/).
| | Sample_platform_id | GPL570
| | Sample_contact_name | Yuan,,Liu
| | Sample_contact_fax | 610-917-5000
| | Sample_contact_department | Biomarker
| | Sample_contact_institute | GlaxoSmithKline
| | Sample_contact_address | 1250 South Collegeville Rd
| | Sample_contact_city | Collegeville
| | Sample_contact_state | PA
| | Sample_contact_zip/postal_code | 19446
| | Sample_contact_country | USA
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM799nnn/GSM799175/suppl/GSM799175.CEL.gz
| | Sample_series_id | GSE16179
| | Sample_data_row_count | 54675
| | |
|
GSM799176 | GPL570 |
|
BT474-J4_DMSO_24-3
|
BT474-J4 breast cancer cell line, DMSO
|
cell line: BT474-J4
cell type: breast cancer
lapatinib sensitivity: acquired lapatinib-resistant
her2 status: HER2-positive
treatment: DMSO
|
Gene expression data of a breast cancer cell line.
|
| Sample_geo_accession | GSM799176
| | Sample_status | Public on Sep 20 2011
| | Sample_submission_date | Sep 20 2011
| | Sample_last_update_date | Sep 20 2011
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Homo sapiens
| | Sample_taxid_ch1 | 9606
| | Sample_treatment_protocol_ch1 | Cells were treated with vehicle (DMSO), 1 µM lapatinib, 0.1 µM GSK1363089 (foretinib) or a combination of 1µM lapatinib and 0.1 µM foretinib for 24h.
| | Sample_growth_protocol_ch1 | Cells were plated in RPMI medium containing 10% FBS overnight at 37ºC, 5%CO2.
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Trizol extraction of total RNA was performed according to the manufacturer's instructions.
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | Biotinylated cRNA were prepared according to the standard Affymetrix protocol (Response Genetics, Inc.)
| | Sample_hyb_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_scan_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_data_processing | RNA microarray signals were normalized by MAS5. QC and data analysis were performed using Omicsoft microarray analysis tools (http://www.omicsoft.com/).
| | Sample_platform_id | GPL570
| | Sample_contact_name | Yuan,,Liu
| | Sample_contact_fax | 610-917-5000
| | Sample_contact_department | Biomarker
| | Sample_contact_institute | GlaxoSmithKline
| | Sample_contact_address | 1250 South Collegeville Rd
| | Sample_contact_city | Collegeville
| | Sample_contact_state | PA
| | Sample_contact_zip/postal_code | 19446
| | Sample_contact_country | USA
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM799nnn/GSM799176/suppl/GSM799176.CEL.gz
| | Sample_series_id | GSE16179
| | Sample_data_row_count | 54675
| | |
|
GSM799177 | GPL570 |
|
BT474-J4_GSK089_24-1
|
BT474-J4 breast cancer cell line, foretinib
|
cell line: BT474-J4
cell type: breast cancer
lapatinib sensitivity: acquired lapatinib-resistant
her2 status: HER2-positive
treatment: foretinib
|
Gene expression data of a breast cancer cell line.
|
| Sample_geo_accession | GSM799177
| | Sample_status | Public on Sep 20 2011
| | Sample_submission_date | Sep 20 2011
| | Sample_last_update_date | Sep 20 2011
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Homo sapiens
| | Sample_taxid_ch1 | 9606
| | Sample_treatment_protocol_ch1 | Cells were treated with vehicle (DMSO), 1 µM lapatinib, 0.1 µM GSK1363089 (foretinib) or a combination of 1µM lapatinib and 0.1 µM foretinib for 24h.
| | Sample_growth_protocol_ch1 | Cells were plated in RPMI medium containing 10% FBS overnight at 37ºC, 5%CO2.
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Trizol extraction of total RNA was performed according to the manufacturer's instructions.
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | Biotinylated cRNA were prepared according to the standard Affymetrix protocol (Response Genetics, Inc.)
| | Sample_hyb_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_scan_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_data_processing | RNA microarray signals were normalized by MAS5. QC and data analysis were performed using Omicsoft microarray analysis tools (http://www.omicsoft.com/).
| | Sample_platform_id | GPL570
| | Sample_contact_name | Yuan,,Liu
| | Sample_contact_fax | 610-917-5000
| | Sample_contact_department | Biomarker
| | Sample_contact_institute | GlaxoSmithKline
| | Sample_contact_address | 1250 South Collegeville Rd
| | Sample_contact_city | Collegeville
| | Sample_contact_state | PA
| | Sample_contact_zip/postal_code | 19446
| | Sample_contact_country | USA
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM799nnn/GSM799177/suppl/GSM799177.CEL.gz
| | Sample_series_id | GSE16179
| | Sample_data_row_count | 54675
| | |
|
GSM799178 | GPL570 |
|
BT474-J4_GSK089_24-2
|
BT474-J4 breast cancer cell line, foretinib
|
cell line: BT474-J4
cell type: breast cancer
lapatinib sensitivity: acquired lapatinib-resistant
her2 status: HER2-positive
treatment: foretinib
|
Gene expression data of a breast cancer cell line.
|
| Sample_geo_accession | GSM799178
| | Sample_status | Public on Sep 20 2011
| | Sample_submission_date | Sep 20 2011
| | Sample_last_update_date | Sep 20 2011
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Homo sapiens
| | Sample_taxid_ch1 | 9606
| | Sample_treatment_protocol_ch1 | Cells were treated with vehicle (DMSO), 1 µM lapatinib, 0.1 µM GSK1363089 (foretinib) or a combination of 1µM lapatinib and 0.1 µM foretinib for 24h.
| | Sample_growth_protocol_ch1 | Cells were plated in RPMI medium containing 10% FBS overnight at 37ºC, 5%CO2.
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Trizol extraction of total RNA was performed according to the manufacturer's instructions.
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | Biotinylated cRNA were prepared according to the standard Affymetrix protocol (Response Genetics, Inc.)
| | Sample_hyb_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_scan_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_data_processing | RNA microarray signals were normalized by MAS5. QC and data analysis were performed using Omicsoft microarray analysis tools (http://www.omicsoft.com/).
| | Sample_platform_id | GPL570
| | Sample_contact_name | Yuan,,Liu
| | Sample_contact_fax | 610-917-5000
| | Sample_contact_department | Biomarker
| | Sample_contact_institute | GlaxoSmithKline
| | Sample_contact_address | 1250 South Collegeville Rd
| | Sample_contact_city | Collegeville
| | Sample_contact_state | PA
| | Sample_contact_zip/postal_code | 19446
| | Sample_contact_country | USA
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM799nnn/GSM799178/suppl/GSM799178.CEL.gz
| | Sample_series_id | GSE16179
| | Sample_data_row_count | 54675
| | |
|
GSM799179 | GPL570 |
|
BT474-J4_GSK089_24-3
|
BT474-J4 breast cancer cell line, foretinib
|
cell line: BT474-J4
cell type: breast cancer
lapatinib sensitivity: acquired lapatinib-resistant
her2 status: HER2-positive
treatment: foretinib
|
Gene expression data of a breast cancer cell line.
|
| Sample_geo_accession | GSM799179
| | Sample_status | Public on Sep 20 2011
| | Sample_submission_date | Sep 20 2011
| | Sample_last_update_date | Sep 20 2011
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Homo sapiens
| | Sample_taxid_ch1 | 9606
| | Sample_treatment_protocol_ch1 | Cells were treated with vehicle (DMSO), 1 µM lapatinib, 0.1 µM GSK1363089 (foretinib) or a combination of 1µM lapatinib and 0.1 µM foretinib for 24h.
| | Sample_growth_protocol_ch1 | Cells were plated in RPMI medium containing 10% FBS overnight at 37ºC, 5%CO2.
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Trizol extraction of total RNA was performed according to the manufacturer's instructions.
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | Biotinylated cRNA were prepared according to the standard Affymetrix protocol (Response Genetics, Inc.)
| | Sample_hyb_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_scan_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_data_processing | RNA microarray signals were normalized by MAS5. QC and data analysis were performed using Omicsoft microarray analysis tools (http://www.omicsoft.com/).
| | Sample_platform_id | GPL570
| | Sample_contact_name | Yuan,,Liu
| | Sample_contact_fax | 610-917-5000
| | Sample_contact_department | Biomarker
| | Sample_contact_institute | GlaxoSmithKline
| | Sample_contact_address | 1250 South Collegeville Rd
| | Sample_contact_city | Collegeville
| | Sample_contact_state | PA
| | Sample_contact_zip/postal_code | 19446
| | Sample_contact_country | USA
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM799nnn/GSM799179/suppl/GSM799179.CEL.gz
| | Sample_series_id | GSE16179
| | Sample_data_row_count | 54675
| | |
|
GSM799181 | GPL570 |
|
BT474-J4_Lap_24-2
|
BT474-J4 breast cancer cell line, lapatinib
|
cell line: BT474-J4
cell type: breast cancer
lapatinib sensitivity: acquired lapatinib-resistant
her2 status: HER2-positive
treatment: lapatinib
|
Gene expression data of a breast cancer cell line.
|
| Sample_geo_accession | GSM799181
| | Sample_status | Public on Sep 20 2011
| | Sample_submission_date | Sep 20 2011
| | Sample_last_update_date | Sep 20 2011
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Homo sapiens
| | Sample_taxid_ch1 | 9606
| | Sample_treatment_protocol_ch1 | Cells were treated with vehicle (DMSO), 1 µM lapatinib, 0.1 µM GSK1363089 (foretinib) or a combination of 1µM lapatinib and 0.1 µM foretinib for 24h.
| | Sample_growth_protocol_ch1 | Cells were plated in RPMI medium containing 10% FBS overnight at 37ºC, 5%CO2.
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Trizol extraction of total RNA was performed according to the manufacturer's instructions.
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | Biotinylated cRNA were prepared according to the standard Affymetrix protocol (Response Genetics, Inc.)
| | Sample_hyb_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_scan_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_data_processing | RNA microarray signals were normalized by MAS5. QC and data analysis were performed using Omicsoft microarray analysis tools (http://www.omicsoft.com/).
| | Sample_platform_id | GPL570
| | Sample_contact_name | Yuan,,Liu
| | Sample_contact_fax | 610-917-5000
| | Sample_contact_department | Biomarker
| | Sample_contact_institute | GlaxoSmithKline
| | Sample_contact_address | 1250 South Collegeville Rd
| | Sample_contact_city | Collegeville
| | Sample_contact_state | PA
| | Sample_contact_zip/postal_code | 19446
| | Sample_contact_country | USA
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM799nnn/GSM799181/suppl/GSM799181.CEL.gz
| | Sample_series_id | GSE16179
| | Sample_data_row_count | 54675
| | |
|
GSM799182 | GPL570 |
|
BT474-J4_Lap_24-3
|
BT474-J4 breast cancer cell line, lapatinib
|
cell line: BT474-J4
cell type: breast cancer
lapatinib sensitivity: acquired lapatinib-resistant
her2 status: HER2-positive
treatment: lapatinib
|
Gene expression data of a breast cancer cell line.
|
| Sample_geo_accession | GSM799182
| | Sample_status | Public on Sep 20 2011
| | Sample_submission_date | Sep 20 2011
| | Sample_last_update_date | Sep 20 2011
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Homo sapiens
| | Sample_taxid_ch1 | 9606
| | Sample_treatment_protocol_ch1 | Cells were treated with vehicle (DMSO), 1 µM lapatinib, 0.1 µM GSK1363089 (foretinib) or a combination of 1µM lapatinib and 0.1 µM foretinib for 24h.
| | Sample_growth_protocol_ch1 | Cells were plated in RPMI medium containing 10% FBS overnight at 37ºC, 5%CO2.
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Trizol extraction of total RNA was performed according to the manufacturer's instructions.
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | Biotinylated cRNA were prepared according to the standard Affymetrix protocol (Response Genetics, Inc.)
| | Sample_hyb_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_scan_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_data_processing | RNA microarray signals were normalized by MAS5. QC and data analysis were performed using Omicsoft microarray analysis tools (http://www.omicsoft.com/).
| | Sample_platform_id | GPL570
| | Sample_contact_name | Yuan,,Liu
| | Sample_contact_fax | 610-917-5000
| | Sample_contact_department | Biomarker
| | Sample_contact_institute | GlaxoSmithKline
| | Sample_contact_address | 1250 South Collegeville Rd
| | Sample_contact_city | Collegeville
| | Sample_contact_state | PA
| | Sample_contact_zip/postal_code | 19446
| | Sample_contact_country | USA
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM799nnn/GSM799182/suppl/GSM799182.CEL.gz
| | Sample_series_id | GSE16179
| | Sample_data_row_count | 54675
| | |
|
GSM799183 | GPL570 |
|
BT474-J4_Lap-GSK089_24-1
|
BT474-J4 breast cancer cell line, lapatinib and foretinib
|
cell line: BT474-J4
cell type: breast cancer
lapatinib sensitivity: acquired lapatinib-resistant
her2 status: HER2-positive
treatment: lapatinib and foretinib
|
Gene expression data of a breast cancer cell line.
|
| Sample_geo_accession | GSM799183
| | Sample_status | Public on Sep 20 2011
| | Sample_submission_date | Sep 20 2011
| | Sample_last_update_date | Sep 20 2011
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Homo sapiens
| | Sample_taxid_ch1 | 9606
| | Sample_treatment_protocol_ch1 | Cells were treated with vehicle (DMSO), 1 µM lapatinib, 0.1 µM GSK1363089 (foretinib) or a combination of 1µM lapatinib and 0.1 µM foretinib for 24h.
| | Sample_growth_protocol_ch1 | Cells were plated in RPMI medium containing 10% FBS overnight at 37ºC, 5%CO2.
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Trizol extraction of total RNA was performed according to the manufacturer's instructions.
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | Biotinylated cRNA were prepared according to the standard Affymetrix protocol (Response Genetics, Inc.)
| | Sample_hyb_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_scan_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_data_processing | RNA microarray signals were normalized by MAS5. QC and data analysis were performed using Omicsoft microarray analysis tools (http://www.omicsoft.com/).
| | Sample_platform_id | GPL570
| | Sample_contact_name | Yuan,,Liu
| | Sample_contact_fax | 610-917-5000
| | Sample_contact_department | Biomarker
| | Sample_contact_institute | GlaxoSmithKline
| | Sample_contact_address | 1250 South Collegeville Rd
| | Sample_contact_city | Collegeville
| | Sample_contact_state | PA
| | Sample_contact_zip/postal_code | 19446
| | Sample_contact_country | USA
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM799nnn/GSM799183/suppl/GSM799183.CEL.gz
| | Sample_series_id | GSE16179
| | Sample_data_row_count | 54675
| | |
|
GSM799184 | GPL570 |
|
BT474-J4_Lap-GSK089_24-2
|
BT474-J4 breast cancer cell line, lapatinib and foretinib
|
cell line: BT474-J4
cell type: breast cancer
lapatinib sensitivity: acquired lapatinib-resistant
her2 status: HER2-positive
treatment: lapatinib and foretinib
|
Gene expression data of a breast cancer cell line.
|
| Sample_geo_accession | GSM799184
| | Sample_status | Public on Sep 20 2011
| | Sample_submission_date | Sep 20 2011
| | Sample_last_update_date | Sep 20 2011
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Homo sapiens
| | Sample_taxid_ch1 | 9606
| | Sample_treatment_protocol_ch1 | Cells were treated with vehicle (DMSO), 1 µM lapatinib, 0.1 µM GSK1363089 (foretinib) or a combination of 1µM lapatinib and 0.1 µM foretinib for 24h.
| | Sample_growth_protocol_ch1 | Cells were plated in RPMI medium containing 10% FBS overnight at 37ºC, 5%CO2.
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Trizol extraction of total RNA was performed according to the manufacturer's instructions.
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | Biotinylated cRNA were prepared according to the standard Affymetrix protocol (Response Genetics, Inc.)
| | Sample_hyb_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_scan_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_data_processing | RNA microarray signals were normalized by MAS5. QC and data analysis were performed using Omicsoft microarray analysis tools (http://www.omicsoft.com/).
| | Sample_platform_id | GPL570
| | Sample_contact_name | Yuan,,Liu
| | Sample_contact_fax | 610-917-5000
| | Sample_contact_department | Biomarker
| | Sample_contact_institute | GlaxoSmithKline
| | Sample_contact_address | 1250 South Collegeville Rd
| | Sample_contact_city | Collegeville
| | Sample_contact_state | PA
| | Sample_contact_zip/postal_code | 19446
| | Sample_contact_country | USA
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM799nnn/GSM799184/suppl/GSM799184.CEL.gz
| | Sample_series_id | GSE16179
| | Sample_data_row_count | 54675
| | |
|
GSM799185 | GPL570 |
|
BT474-J4_Lap-GSK089_24-3
|
BT474-J4 breast cancer cell line, lapatinib and foretinib
|
cell line: BT474-J4
cell type: breast cancer
lapatinib sensitivity: acquired lapatinib-resistant
her2 status: HER2-positive
treatment: lapatinib and foretinib
|
Gene expression data of a breast cancer cell line.
|
| Sample_geo_accession | GSM799185
| | Sample_status | Public on Sep 20 2011
| | Sample_submission_date | Sep 20 2011
| | Sample_last_update_date | Sep 20 2011
| | Sample_type | RNA
| | Sample_channel_count | 1
| | Sample_organism_ch1 | Homo sapiens
| | Sample_taxid_ch1 | 9606
| | Sample_treatment_protocol_ch1 | Cells were treated with vehicle (DMSO), 1 µM lapatinib, 0.1 µM GSK1363089 (foretinib) or a combination of 1µM lapatinib and 0.1 µM foretinib for 24h.
| | Sample_growth_protocol_ch1 | Cells were plated in RPMI medium containing 10% FBS overnight at 37ºC, 5%CO2.
| | Sample_molecule_ch1 | total RNA
| | Sample_extract_protocol_ch1 | Trizol extraction of total RNA was performed according to the manufacturer's instructions.
| | Sample_label_ch1 | biotin
| | Sample_label_protocol_ch1 | Biotinylated cRNA were prepared according to the standard Affymetrix protocol (Response Genetics, Inc.)
| | Sample_hyb_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_scan_protocol | Experiment conducted at Response Genetics, Inc.
| | Sample_data_processing | RNA microarray signals were normalized by MAS5. QC and data analysis were performed using Omicsoft microarray analysis tools (http://www.omicsoft.com/).
| | Sample_platform_id | GPL570
| | Sample_contact_name | Yuan,,Liu
| | Sample_contact_fax | 610-917-5000
| | Sample_contact_department | Biomarker
| | Sample_contact_institute | GlaxoSmithKline
| | Sample_contact_address | 1250 South Collegeville Rd
| | Sample_contact_city | Collegeville
| | Sample_contact_state | PA
| | Sample_contact_zip/postal_code | 19446
| | Sample_contact_country | USA
| | Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM799nnn/GSM799185/suppl/GSM799185.CEL.gz
| | Sample_series_id | GSE16179
| | Sample_data_row_count | 54675
| | |
|
| |
| |
Make groups for comparisons |
(2 groups will be compared at a time) |
|
| Select GSMs and click on "Add groups" |
Enter the group name here: |
|
|
|
